Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(25%)

    Phase Distribution

    Phase 1/2
    1
    25%
    Phase 2
    1
    25%
    Early Phase 1
    2
    50%

    Phase Distribution

    2

    Early Stage

    2

    Mid Stage

    0

    Late Stage

    Phase Distribution4 total trials
    Early Phase 1First-in-human
    2(50.0%)
    Phase 1/2Combined phases
    1(25.0%)
    Phase 2Efficacy & side effects
    1(25.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Active(1)
    Other(3)

    Detailed Status

    unknown2
    Suspended1
    Recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    1
    Success Rate
    N/A
    Most Advanced
    Phase 2

    Trials by Phase

    Early Phase 12 (50.0%)
    Phase 1/21 (25.0%)
    Phase 21 (25.0%)

    Trials by Status

    suspended125%
    recruiting125%
    unknown250%

    Recent Activity

    1 active trials
    Showing 4 of 4
    recruitingphase_1_2

    Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing

    NCT07508033
    suspendedearly_phase_1

    Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

    NCT07146087
    unknownphase_2

    Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis

    NCT05871463
    unknownearly_phase_1

    Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

    NCT05808400

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT07508033Phase 1/2

    Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing

    Recruiting
    NCT07146087Early Phase 1

    Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

    Suspended
    NCT05871463Phase 2

    Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis

    Unknown
    NCT05808400Early Phase 1

    Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

    Unknown

    All 4 trials loaded

    Drug Details

    Intervention Type
    Biological
    Total Trials
    4